Sunday, March 30, 2025 3:10:12 PM
In one post you told me that only violating S-K, Item 404 would not land Powers in prison (and its good to know you admitted Powers did violate S-K, Item 404) then on your specific request I posted a long list of SEC regulations she did violate what could land her in jail and then the next post you complain its the kitchen sink. You really don't know what you want do you? Do you think its strange everyone here calls you flip flop?
1. They have never disclosed Advent is a privately held CDMO by the CEO as required by SEC. Quote the company that they have as you claim
2. They have never received ASM approval to fund Advent with shareholders' money as required by SEC. Bring proof forward that they have as you claim
3. They have not installed an independent Board Oversight to oversee the funds funneled into Advent as required by SEC. Bring proof forward that they have as you claim
These 3 violations resulted in the SEC violations as described here https://investorshub.advfn.com/boards/replies.aspx?msg=175994630
I understand its all bid too much for you and very complex, try to focus on your new hobby after April 7.
1. They have never disclosed Advent is a privately held CDMO by the CEO as required by SEC. Quote the company that they have as you claim
2. They have never received ASM approval to fund Advent with shareholders' money as required by SEC. Bring proof forward that they have as you claim
3. They have not installed an independent Board Oversight to oversee the funds funneled into Advent as required by SEC. Bring proof forward that they have as you claim
These 3 violations resulted in the SEC violations as described here https://investorshub.advfn.com/boards/replies.aspx?msg=175994630
I understand its all bid too much for you and very complex, try to focus on your new hobby after April 7.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
